SECURITIES AND EXCHANGE COMMISSION
                              Washington, DC 20549
                                  -------------
                                  FORM 10-QSB/A
                                (Amendment No. 1)

(Mark One)
|X|   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
      EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2002

                                       OR

|_|   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
      EXCHANGE ACT OF 1934

For the transition period from _____________ to ______________


                         Commission file number: 0-20580


                           LIFE MEDICAL SCIENCES, INC.
             (Exact name of registrant as specified in its charter)


           Delaware                                              14-1745197
(State or other jurisdiction of                              (I.R.S. Employer
 incorporation or organization)                              Identification No.)

  PO Box 219, Little Silver, New Jersey                                07739
(Address of principal executive offices)                             (Zip Code)



                                 (732) 728-1769
                (Issuer's telephone number, including area code)

      Check whether the issuer: (1) has filed all reports required to be filed
by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the
preceding 12 months (or for such shorter period that the registrant was required
to file such reports), and (2) has been subject to such filing requirements for
the past 90 days. Yes |X| No |_|

      Indicate the number of shares outstanding of each of the issuer's classes
of common stock, as of the latest practicable date.

                Common Stock, $.001 Par Value - 15,535,650 shares
                           outstanding at May 8, 2001

      Transitional Small Business Disclosure Format (check one):
Yes |_|   No |X|


                                EXPLANATORY NOTE

This Amendment is being filed to accurately reflect on the cover page hereof the
number of outstanding shares of common stock of the issuer.

                                    SIGNATURE

In accordance with the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this Amendment to be signed on its behalf by the
undersigned, thereunto duly authorized.


                                         Life Medical Sciences, Inc.
                                         (Registrant)


Date: May 13, 2002                        /s/ Robert P. Hickey
                                         --------------------------------
                                         Robert P. Hickey
                                         Chairman, President, CEO and CFO


                                       2